Linoleic acid metabolite suppresses skin inflammation and tumor promotion in mice: Possible roles of programmed cell death 4 induction

Carcinogenesis

Volumn 30, Issue 7, 2009, Pages 1209-1216

  Yasuda, Michiko ^a   Nishizawa, Takashi ^a   Ohigashi, Hajime ^a,e   Tanaka, Takuji ^b   Hou, De Xing ^c   Colburn, Nancy H ^d   Murakami, Akira ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

^d NATIONAL CANCER INSTITUTE   (United States)

^e FUKUI PREFECTURAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

13 HYDROXY10 OXO TRANS 11 OCTADECENOIC ACID; CELL PROTEIN; LINOLEIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROGRAMMED CELL DEATH 4; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CELL COUNT; CELL INFILTRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; HISTOLOGY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKIN CARCINOGENESIS; SKIN INFLAMMATION; SKIN TUMOR; TRANSACTIVATION; TUMOR PROMOTION; TUMOR VOLUME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; APOPTOSIS REGULATORY PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; DERMATITIS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FATTY ACIDS, UNSATURATED; FEMALE; LINOLEIC ACID; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED ICR; RNA-BINDING PROTEINS; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR AP-1; TUMOR SUPPRESSOR PROTEINS;

EID: 67650118807     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp106     Document Type: Article

References (50)

1. Naito,M. et al. (1989) Genetic background and development of skin tumors. Carcinog. Compr. Surv., 11, 187-212.
2. Yuspa,S. (1994) The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis-thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res., 54, 1178-1189.
3. DiGiovanni,J. et al. (1994) Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis. Prog. Clin. Biol. Res., 387, 113-138.
4. Mueller,M. (2006) Inflammation in epithelial skin tumours: Old stories and new ideas. Eur. J. Cancer, 42, 735-744.
5. Colburn,N. et al. (1979) Tumour promoter induces anchorage independence irreversibly. Nature, 281, 589-591.
6. Bernstein,L. et al. (1989) AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science, 244, 566-569.
7. Dhar,A. et al. (2002) The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: The JB6 model is predictive. Mol. Cell. Biochem. 234-235, 185-193.
8. Ma,C. et al. (2007) The role of glycogen synthase kinase 3beta in the transformation of epidermal cells. Cancer Res., 67, 7756-7764.
9. Shibahara,K. et al. (1995) Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. Gene, 166, 297-301.
10. Göke,A. et al. (2002) DUG is a novel homologue of translation initiation factor 4G that binds eIF4A. Biochem. Biophys. Res. Commun. 297, 78-82.
11. Cmarik,J. et al. (1999) Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc. Natl Acad. Sci. USA, 96, 14037-14042.
12. Yang,H. et al. (2001) A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene, 20, 669-676.
13. Jansen,A. et al. (2005) Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res., 65, 6034-6041.
14. Zhang,Z. et al. (2001) Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor. Oncogene, 20, 4450-4456.
15. Ozpolat,B. et al. (2007) Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells. Mol. Cancer Res., 5, 95-108.
16. Hayashi,Y. et al. (1996) A new cytotoxic compound from a water extract of corn. Biosci. Biotechnol. Biochem., 60, 1115-1117.
17. Kuga,H. et al. (1993) Isolation and characterization of cytotoxic compounds from corn. Biosci. Biotechnol. Biochem., 57, 1020-1021.
18. Murakami,A. et al. (2005) New class of linoleic acid metabolites biosynthesized by corn and rice lipoxygenases: Suppression of proinflammatory mediator expression via attenuation of MAPK- and Akt-, but not PPARgamma-, dependent pathways in stimulated macrophages. Biochem. Pharmacol., 70, 1330-1342.
19. Lin,S. et al. (2003) Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway. Int. J. Oncol., 22, 829-833.
20. Murakami,A. et al. (1992) Chalcone tetramers, lophirachalcone and alatachalcone, from Lophira alata as possible anti-tumor promoters. Biosci. Biotechnol. Biochem., 56, 769-772.
21. Murakami,A. et al. (2000) Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res., 60, 5059-5066.
22. Chang,P. et al. (2003) Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells. Carcinogenesis, 24, 1749-1758.
23. Liu,G. et al. (2003) NS-398 and piroxicam suppress UVB-induced activator protein 1 activity by mechanisms independent of cyclooxygenase-2. J. Biol. Chem., 278, 2124-2130.
24. Watts,R. et al. (1998) Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene 17, 3493-3498.
25. Huang,C. et al. (1998) Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc. Natl Acad. Sci. USA, 95, 156-161.
26. Yang,H. et al. (2003) Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene, 22, 3712-3720.
27. Yang,H. et al. (2006) Tumorigenesis suppressor Pdcd4 down-regulates mitogen-activated protein kinase kinase kinase kinase 1 expression to suppress colon carcinoma cell invasion. Mol. Cell. Biol., 26, 1297-1306.
28. Wang,Q. et al. (2008) Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene, 27, 1527-1535.
29. Ha,Y. et al. (1987) Anticarcinogens from fried ground beef: heat-altered derivatives of linoleic acid. Carcinogenesis, 8 1881-1887.
30. Yoshizawa,S. et al. (1990) Tumor-promoting activity of staurosporine, a protein kinase inhibitor on mouse skin. Cancer Res. 50, 4974-4978.
31. Liu,G. et al. (2001) Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proc. Natl Acad. Sci. USA, 98, 7510-7515.
32. Young,M. et al. (1999) Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl Acad. Sci. USA, 96, 9827-9832.
33. Young,M. et al. (2002) Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol. Cell. Biol., 22, 587-598.
34. Bernstein,L. et al. (1999) Tumor promotion resistant cells are deficient in AP-1 DNA binding, JunD DNA binding and JunD expression and form different AP-1-DNA complexes than promotion sensitive cells. Biochim. Biophys. Acta, 1489, 263-280.
35. Hou,D. et al. (2004) Anthocyanidins inhibit activator protein 1 activity and cell transformation: Structure-activity relationship and molecular mechanisms. Carcinogenesis, 25, 29-36.
36. Huang,C. et al. (1999) JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol- 13-acetate. J. Biol. Chem., 274, 29672-29676.
37. Liu,G. et al. (2001) Two novel glycosides from the fruits of Morinda citrifolia (noni) inhibit AP-1 transactivation and cell transformation in the mouse epidermal JB6 cell line. Cancer Res., 61, 5749-5756.
38. Nishino,H. et al. (2004) Cancer prevention by antioxidants. Biofactors, 22, 57-61.
39. Murakami,A. et al. (2004) Zerumbone, a sesquiterpene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice. Int. J. Cancer, 110, 481-490.
40. Murakami,A. et al. (1996) 1′-Acetoxychavicol acetate, a superoxide anion generation inhibitor, potently inhibits tumor promotion by 12-O-tetradecanoylphorbol-13-acetate in ICR mouse skin. Oncology 53, 386-391.
41. Nakamura,Y. et al. (1998) Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1′-acetoxychavicol acetate. Cancer Res., 58, 4832-4839.
42. Matsuhashi,S. et al. (2007) Expression patterns of programmed cell death 4 protein in normal human skin and some representative skin lesions. Exp. Dermatol., 16, 179-184.
43. Bannenberg,G. et al. (2004) Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration. Br. J. Pharmacol., 143, 43-52.
44. Wu,S. et al. (2006) Lipoxin A4 inhibits proliferation of human lung fibroblasts induced by connective tissue growth factor. Am. J. Respir. Cell Mol. Biol., 34, 65-72.
45. Appl,H. et al. (2002) Targeted disruption of c-myb in the chicken pre B-cell line DT40. Oncogene, 21, 3076-3081.
46. Asangani,I. et al. (2007) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
47. Talotta,F. et al. (2009) An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 28, 73-84.
48. Chen,A. et al. (2008) Complementary analysis of microRNA and mRNA expression during phorbol 12-myristate 13-acetate (TPA)-induced differentiation of HL-60 cells. Biotechnol. Lett., 30, 2045-2052.
49. Dorrello,N. et al. (2006) S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science, 314, 467-471.
50. Schmid,T. et al. (2008) Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion. Cancer Res., 68, 1254-1260.